You are here

  • Home
  • Archive
  • Volume 78, Issue Suppl 2
  • FRI0418 SECUKINUMAB PROVIDED SIMILAR EFFICACY IN MALES AND FEMALES WITH ACTIVE ANKYLOSING SPONDYLITIS OVER 52 WEEKS: POST HOC POOLED ANALYSIS OF THE MEASURE TRIALS

Article metrics

Article menu

Download PDFPDF

Spondyloarthritis – treatment
FRI0418 SECUKINUMAB PROVIDED SIMILAR EFFICACY IN MALES AND FEMALES WITH ACTIVE ANKYLOSING SPONDYLITIS OVER 52 WEEKS: POST HOC POOLED ANALYSIS OF THE MEASURE TRIALS
Free

 

Online download statistics by month:

Online download statistics by month: June 2019 to March 2024

AbstractFullPdf
Jun 201933022
Jul 201924014
Aug 2019604
Sep 20191804
Oct 20191404
Nov 20191706
Dec 2019901
Jan 20202308
Feb 20202704
Mar 202039010
Apr 20202403
May 20202407
Jun 20202804
Jul 20201704
Aug 2020201
Sep 20204008
Oct 20202008
Nov 20202205
Dec 20205306
Jan 20211708
Feb 20212207
Mar 202127018
Apr 202110014
May 20211006
Jun 2021005
Jul 2021105
Aug 2021001
Sep 2021104
Oct 20217017
Nov 202118014
Dec 20212702
Jan 2022201
Feb 20222503
Mar 20222103
Apr 2022805
May 202216010
Jun 20222605
Jul 20223104
Aug 20222603
Sep 20221404
Oct 20221404
Nov 20221301
Dec 20222403
Jan 20231802
Feb 2023904
Mar 20231800
Apr 2023900
May 20231602
Jun 2023902
Jul 20231407
Aug 20235010
Sep 202317011
Oct 20232003
Nov 20231507
Dec 20233403
Jan 20242203
Feb 20241600
Mar 202416020
Total10380344